Cancer News
AI-informed context on recent cancer research and oncology news

Understanding Resistance in Pancreatic Cancer: The Role of PI3K in KRAS Inhibitor Efficacy
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings have illuminated the complexities of treating pancreatic cancer, particularly highlighting the mechanisms behind resistance to KRAS inhibitors. This research, which explores the...
Read more →
Understanding KRAS Inhibitor Resistance: The Role of PI3K in Pancreatic Cancer
June 7, 2026
Based on reporting from Newswise: MedNews
Recent research has highlighted a significant challenge in treating pancreatic cancer—resistance to KRAS inhibitors. A study published by researchers reveals that the protein PI3K can activate...
Read more →
Bridging the Information Gap: The Need for Accessible AI Resources in Cancer Care
June 7, 2026
Based on reporting from Newswise: Latest News
In an era where patients increasingly turn to the internet for health information, recent research highlights significant shortcomings in the quality and clarity of online resources regarding...
Read more →
Shortcomings in Online Resources for Patients Regarding AI in Cancer Care
June 7, 2026
Based on reporting from Newswise: MedNews
In an era where the integration of artificial intelligence (AI) is increasingly influencing cancer research and treatment, a recent study highlights significant deficiencies in the quality and...
Read more →
New Insights on Apalutamide's Role in High-Risk Prostate Cancer Treatment
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings from a phase 3 clinical trial have revealed promising results for high-risk localized or locally advanced prostate cancer patients treated with apalutamide in conjunction with...
Read more →
New Insights on Apalutamide in High-Risk Prostate Cancer: A Potential Game Changer
June 7, 2026
Based on reporting from Newswise: MedNews
Recent findings presented at the American Society for Clinical Oncology (ASCO) Annual Meeting have unveiled significant advancements in the treatment of high-risk localized or locally advanced...
Read more →
Breakthrough Phase 3 Trial for Daraxonrasib Offers Hope for Pancreatic Cancer Patients
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings from the RASolute 302 trial have brought a wave of optimism in the treatment of metastatic pancreatic cancer, a notoriously aggressive disease. This pivotal study has shown that...
Read more →
New RAS(ON) Inhibitor Shows Promise in Phase 3 Trial for Metastatic Pancreatic Cancer
June 7, 2026
Based on reporting from Newswise: MedNews
Recent findings from the pivotal RASolute 302 trial have introduced a new treatment option that could significantly improve outcomes for patients suffering from metastatic pancreatic cancer. The...
Read more →
Revolutionary Tile-Based Radiation Therapy Shows Promise for Brain Metastases
June 7, 2026
Based on reporting from Newswise: MedNews
Recent findings from a multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking approach to treating brain metastases. This...
Read more →
Revolutionary Tile-Based Radiation Therapy Shows Promise in Reducing Brain Tumor Recurrence
June 7, 2026
Based on reporting from Newswise: SciNews
Recent advancements in oncology have unveiled a groundbreaking approach to treating brain metastases, a challenging complication for many cancer patients. A multicenter clinical trial has...
Read more →
Tile-Based Radiation Therapy Revolutionizes Treatment for Brain Metastases
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings from a multicenter clinical trial have illuminated a groundbreaking approach to treating brain metastases, significantly enhancing patient outcomes. This innovative method, known as...
Read more →
Understanding the Role of Peptides and Screening in Colorectal Cancer and Beyond
June 7, 2026
Based on reporting from KFF Health News
In a recent discussion on CBS Mornings, health expert Céline Gounder shed light on several critical topics in modern medicine, including the significance of peptides, advancements in colorectal...
Read more →
Enhancing Cancer Care Through Streamlined Lab Processes: The Impact of CLSI AUTO15
June 7, 2026
Based on reporting from Newswise: MedNews
In the fast-paced environment of cancer treatment, the speed and accuracy of lab test results play a crucial role in patient outcomes. A recent case study from Stanford Cancer Center South Bay...
Read more →
Revolutionizing Cancer Care: The Impact of Autoverification on Test Result Efficiency at Stanford Cancer Center
June 7, 2026
Based on reporting from Newswise: Latest News
In a bid to enhance the speed and accuracy of vital test results, Stanford Cancer Center South Bay has successfully implemented the CLSI AUTO15 autoverification system. This innovative approach...
Read more →
Virginia Tech Launches Groundbreaking Clinical Trial Using Focused Ultrasound for Equine Tumors
June 7, 2026
Based on reporting from Newswise: SciNews
In a pioneering effort that could revolutionize veterinary oncology, researchers at Virginia Tech are conducting a world-first clinical trial aimed at treating sarcoid tumors in horses using focused...
Read more →
NYC for MSK Campaign: Community Support Fuels Lifesaving Cancer Research
June 7, 2026
Based on reporting from Newswise: Latest News
Memorial Sloan Kettering Cancer Center (MSK) recently celebrated the kickoff of its third annual NYC for MSK campaign, an initiative designed to raise vital funds for cancer research and patient...
Read more →
Teclistamab: A Promising Breakthrough in Relapsed Multiple Myeloma Treatment
June 7, 2026
Based on reporting from Newswise: MedNews
In a groundbreaking phase 3 clinical trial, researchers have demonstrated that teclistamab, an innovative immunotherapy, significantly improves survival rates and deepens remission for patients...
Read more →
Sunvozertinib: A New Hope for Patients with Hard-to-Treat Lung Cancer
June 7, 2026
Based on reporting from Newswise: MedNews
In a significant breakthrough for lung cancer treatment, researchers at The University of Texas MD Anderson Cancer Center have unveiled promising results from their Phase 3 clinical trial of...
Read more →
Teclistamab Shows Promise in Extending Survival for Patients with Relapsed Multiple Myeloma
June 7, 2026
Based on reporting from Newswise: Latest News
In a significant advancement for cancer treatment, a recent international trial has demonstrated that teclistamab, an innovative immunotherapy, offers substantial benefits for patients suffering from...
Read more →
Promising New Treatment Sunvozertinib Outshines Chemotherapy for Advanced Lung Cancer
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting have revealed that the targeted therapy sunvozertinib may provide a more effective treatment option...
Read more →